R. Deans

20.9k total citations · 2 hit papers
19 papers, 16.0k citations indexed

About

R. Deans is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, R. Deans has authored 19 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Surgery. Recurrent topics in R. Deans's work include Mesenchymal stem cell research (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and T-cell and B-cell Immunology (3 papers). R. Deans is often cited by papers focused on Mesenchymal stem cell research (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and T-cell and B-cell Immunology (3 papers). R. Deans collaborates with scholars based in United States, Sweden and Italy. R. Deans's co-authors include Ingo Mueller, Massimo Dominici, Katarina Le Blanc, Ineke Slaper‐Cortenbach, Armand Keating, Edwin M. Horwitz, F. Marini, Diane S. Krause, Darwin J. Prockop and F C Marini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

R. Deans

19 papers receiving 15.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

2006 13.5k citations Massimo Dominici, Katarina Le Blanc et al. Cytotherapy profile →
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

2005 1.5k citations E.M. Horwitz, Katarina Le Blanc et al. Cytotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Deans United States	13	11.0k	6.0k	4.5k	1.9k	1.8k	19	16.0k
Ineke Slaper‐Cortenbach Netherlands	21	11.3k 1.0×	6.3k 1.0×	4.6k 1.0×	2.0k 1.0×	1.8k 1.0×	49	16.2k
Ingo Mueller Germany	12	11.0k 1.0×	6.1k 1.0×	4.4k 1.0×	1.9k 1.0×	1.8k 1.0×	23	15.4k
Stewart Craig United States	23	10.5k 1.0×	5.7k 1.0×	7.1k 1.6×	2.3k 1.2×	2.3k 1.3×	38	20.0k
F. Marini Italy	25	10.6k 1.0×	5.7k 0.9×	6.5k 1.4×	1.8k 1.0×	2.4k 1.4×	43	17.1k
Rama K. Jaiswal United States	15	10.7k 1.0×	5.8k 1.0×	6.8k 1.5×	2.3k 1.2×	1.9k 1.1×	18	18.6k
Joseph D. Mosca United States	17	12.5k 1.1×	6.6k 1.1×	6.7k 1.5×	2.6k 1.4×	2.1k 1.2×	28	20.0k
Mark A. Moorman United States	22	11.4k 1.0×	7.7k 1.3×	7.4k 1.6×	2.4k 1.3×	2.0k 1.1×	29	20.9k
Alastair M. Mackay United States	20	11.6k 1.1×	6.4k 1.1×	7.3k 1.6×	2.6k 1.4×	2.0k 1.1×	33	20.2k
Stephen C. Beck United States	11	11.3k 1.0×	6.2k 1.0×	6.5k 1.4×	2.5k 1.3×	1.8k 1.0×	12	19.2k
Frank Barry Ireland	61	8.8k 0.8×	5.0k 0.8×	4.5k 1.0×	2.1k 1.1×	1.7k 1.0×	176	16.0k

Countries citing papers authored by R. Deans

Since Specialization

Citations

This map shows the geographic impact of R. Deans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Deans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Deans more than expected).

Fields of papers citing papers by R. Deans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Deans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Deans. The network helps show where R. Deans may publish in the future.

Co-authorship network of co-authors of R. Deans

This figure shows the co-authorship network connecting the top 25 collaborators of R. Deans. A scholar is included among the top collaborators of R. Deans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Deans. R. Deans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Maziarz, Richard T., Carlos Bachier, Steven C. Goldstein, et al.. (2012). Prophylaxis of Acute GVHD Using Multistem® Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses in a Phase 1 Trial. Biology of Blood and Marrow Transplantation. 18(2). S264–S265. 6 indexed citations

Maziarz, Richard T., Carlos Bachier, Steven C. Goldstein, et al.. (2011). Stromal Stem Cell Therapy for Prophylaxis of Acute GVHD: Preliminary Results From a Phase 1 Trial. Biology of Blood and Marrow Transplantation. 17(2). S222–S223. 2 indexed citations

Kovacsovics‐Bankowski, Magdalena, et al.. (2008). Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy. 10(7). 730–742. 31 indexed citations

Hof, Wouter Van’t, Niladri Mal, Yan Huang, et al.. (2007). Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy. 9(5). 477–487. 43 indexed citations

Dominici, Massimo, Katarina Le Blanc, Ingo Mueller, et al.. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8(4). 315–317. 13453 indexed citations breakdown →

Yasuhara, Takao, Noriyuki Matsukawa, Guolong Yu, et al.. (2006). Transplantation of Cryopreserved Human Bone Marrowderived Multipotent Adult Progenitor Cells for Neonatal Hypoxie- Ischemic Injury: Targeting the Hippocampus. Reviews in the Neurosciences. 17(1-2). 215–25. 28 indexed citations

Kovacsovics-Bankowski, Magdalena, et al.. (2006). Multipotent Adult Progenitor Cells (MAPC) are non-immunogenic and display immunosuppressive properties on activated T cells. Biology of Blood and Marrow Transplantation. 12(2). 106–107. 1 indexed citations

Horwitz, E.M., Katarina Le Blanc, Massimo Dominici, et al.. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 7(5). 393–395. 1492 indexed citations breakdown →

Weiler, Solly, et al.. (1994). Assignment of a Human Melanoma Associated Gene MG50 (D2S448) to Chromosome 2p25.3 by Fluorescence in Situ Hybridization. Genomics. 22(1). 243–244. 11 indexed citations

10.

Peddada, Lorraine, John D. McPherson, R E Law, et al.. (1992). Somatic cell mapping of the human cyclophilin B gene (PPIB) to chromosome 15. Cytogenetic and Genome Research. 60(3-4). 219–221. 8 indexed citations

11.

Uyemura, Koichi, R. Deans, Hamid Band, et al.. (1991). Evidence for clonal selection of gamma/delta T cells in response to a human pathogen.. The Journal of Experimental Medicine. 174(3). 683–692. 81 indexed citations

12.

Linker‐Israeli, Mariana, et al.. (1991). Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. The Journal of Immunology. 147(1). 117–123. 443 indexed citations

13.

Deans, R., et al.. (1991). Novel gene sequences expressed by human melanoma cells identified by molecular subtraction.. PubMed. 51(5). 1418–25. 13 indexed citations

14.

Deans, R., et al.. (1989). Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1).. Molecular and Cellular Biology. 9(5). 2233–2238. 47 indexed citations

15.

Baric, Ralph S., J. O. Fleming, R. Deans, et al.. (1988). Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. Journal of Virology. 62(11). 4280–4287. 156 indexed citations

16.

Sherman, Mark A., R. Deans, & Michael B. Bolger. (1988). Haloperidol binding to monoclonal antibodies. Hypervariable region amino acid sequence determination.. Journal of Biological Chemistry. 263(9). 4059–4063. 12 indexed citations

17.

Stohlman, Stephen A., et al.. (1988). Specific interaction between coronavirus leader RNA and nucleocapsid protein. Journal of Virology. 62(11). 4288–4295. 156 indexed citations

18.

Deans, R., Kathleen Denis, Annette K. Taylor, & Randolph Wall. (1984). Expression of an immunoglobulin heavy chain gene transfected into lymphocytes.. Proceedings of the National Academy of Sciences. 81(5). 1292–1296. 45 indexed citations

19.

Friedman, David J., et al.. (1981). lambda altSF: a phage variant that acquired the ability to substitute specific sets of genes at high frequency.. Proceedings of the National Academy of Sciences. 78(1). 410–414. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact